PE23298A1 - Forma cristalina alternativa de tazofelona - Google Patents
Forma cristalina alternativa de tazofelonaInfo
- Publication number
- PE23298A1 PE23298A1 PE1996000641A PE00064196A PE23298A1 PE 23298 A1 PE23298 A1 PE 23298A1 PE 1996000641 A PE1996000641 A PE 1996000641A PE 00064196 A PE00064196 A PE 00064196A PE 23298 A1 PE23298 A1 PE 23298A1
- Authority
- PE
- Peru
- Prior art keywords
- crystalline form
- tazofelona
- year
- refers
- values
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
SE REFIERE A LA FORMA CRISTALINA II, DEL COMPUESTO ANTIINFLAMATORIO (�)-5-{[3,5-BIS(1,1-DIMETIL ETIL)-4-HIDROXIFENIL]METIL}-4-TIAZOLIDINONA, DE FORMULA (A), CARACTERIZADO POR UN PATRON DE DIFRACCION EN POLVO DE RAYOS X, OBTENIDO CON UNA RADIACION DE CuKO, QUE COMPRENDE 5 VALORES (d) ESPACIO INTERPLANAR, TALES COMO: 5,64 A�; 5,16 A�; 4,90 A�; 4,66 A�; 4,49 A�. TAMBIEN SE REFIERE AL PROCESO DE OBTENCION DE LA FORMA II, QUE COMPRENDE: 1) SUSPENDER LA FORMA CRISTALINA (I) [ QUE COMPRENDE 3 VALORES (d): 7,20 A�; 4,84 A�; 4,76 A� ] EN UN DISOLVENTE ORGANICO, TAL COMO: (ACETATO DE ETILO, TOLUENO o HEPTANO):ACETATO DE ETILO 1:1, A TEMPERATURA AMBIENTE; 2) AGITAR LA SUSPENSION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335695P | 1995-09-07 | 1995-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE23298A1 true PE23298A1 (es) | 1998-05-05 |
Family
ID=21705475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000641A PE23298A1 (es) | 1995-09-07 | 1996-09-02 | Forma cristalina alternativa de tazofelona |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0761656B1 (es) |
| JP (1) | JPH11514978A (es) |
| KR (1) | KR19990044453A (es) |
| CN (1) | CN1082958C (es) |
| AR (2) | AR003483A1 (es) |
| AT (1) | ATE198476T1 (es) |
| AU (1) | AU716684B2 (es) |
| BR (1) | BR9610201A (es) |
| CA (1) | CA2231132A1 (es) |
| CO (1) | CO4750653A1 (es) |
| CZ (1) | CZ68098A3 (es) |
| DE (1) | DE69611407T2 (es) |
| DK (1) | DK0761656T3 (es) |
| EA (1) | EA000258B1 (es) |
| ES (1) | ES2153081T3 (es) |
| GR (1) | GR3035656T3 (es) |
| HU (1) | HUP9901458A3 (es) |
| IN (1) | IN182320B (es) |
| MY (1) | MY132351A (es) |
| NO (1) | NO309719B1 (es) |
| NZ (1) | NZ316810A (es) |
| PE (1) | PE23298A1 (es) |
| PL (1) | PL325602A1 (es) |
| PT (1) | PT761656E (es) |
| SI (1) | SI0761656T1 (es) |
| TR (1) | TR199800398T1 (es) |
| TW (1) | TW460471B (es) |
| WO (1) | WO1997009320A1 (es) |
| ZA (1) | ZA967422B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US538690A (en) * | 1895-05-07 | Automatic watering-trough for animals | ||
| US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
| ZA9010041B (en) * | 1989-12-21 | 1992-08-26 | Lilly Co Eli | Compounds for treating inflammatory bowel disease |
-
1996
- 1996-09-02 DK DK96306336T patent/DK0761656T3/da active
- 1996-09-02 DE DE69611407T patent/DE69611407T2/de not_active Expired - Fee Related
- 1996-09-02 EP EP96306336A patent/EP0761656B1/en not_active Expired - Lifetime
- 1996-09-02 ZA ZA9607422A patent/ZA967422B/xx unknown
- 1996-09-02 SI SI9630287T patent/SI0761656T1/xx unknown
- 1996-09-02 TW TW085110670A patent/TW460471B/zh active
- 1996-09-02 IN IN1563CA1996 patent/IN182320B/en unknown
- 1996-09-02 AR ARP960104198A patent/AR003483A1/es not_active Application Discontinuation
- 1996-09-02 ES ES96306336T patent/ES2153081T3/es not_active Expired - Lifetime
- 1996-09-02 AT AT96306336T patent/ATE198476T1/de not_active IP Right Cessation
- 1996-09-02 AR ARP960104199A patent/AR003484A1/es not_active Application Discontinuation
- 1996-09-02 PT PT96306336T patent/PT761656E/pt unknown
- 1996-09-02 PE PE1996000641A patent/PE23298A1/es not_active Application Discontinuation
- 1996-09-03 NZ NZ316810A patent/NZ316810A/xx unknown
- 1996-09-03 KR KR1019980701701A patent/KR19990044453A/ko not_active Application Discontinuation
- 1996-09-03 EA EA199800275A patent/EA000258B1/ru not_active IP Right Cessation
- 1996-09-03 HU HU9901458A patent/HUP9901458A3/hu unknown
- 1996-09-03 CZ CZ98680A patent/CZ68098A3/cs unknown
- 1996-09-03 AU AU69127/96A patent/AU716684B2/en not_active Ceased
- 1996-09-03 WO PCT/US1996/014132 patent/WO1997009320A1/en not_active Application Discontinuation
- 1996-09-03 JP JP9511339A patent/JPH11514978A/ja active Pending
- 1996-09-03 CA CA002231132A patent/CA2231132A1/en not_active Abandoned
- 1996-09-03 CN CN96197822A patent/CN1082958C/zh not_active Expired - Fee Related
- 1996-09-03 PL PL96325602A patent/PL325602A1/xx unknown
- 1996-09-03 BR BR9610201A patent/BR9610201A/pt not_active Application Discontinuation
- 1996-09-03 TR TR1998/00398T patent/TR199800398T1/xx unknown
- 1996-09-04 MY MYPI96003663A patent/MY132351A/en unknown
- 1996-09-05 CO CO96047346A patent/CO4750653A1/es unknown
-
1998
- 1998-03-03 NO NO980913A patent/NO309719B1/no not_active IP Right Cessation
-
2001
- 2001-03-29 GR GR20010400506T patent/GR3035656T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT54119A (en) | Process for producing antiinflammatory aminophenol derivatives | |
| DE69017642D1 (de) | Vorrichtung zur Herstellung von Einkristallen nach dem Czochralski-Verfahren. | |
| NO20002676D0 (no) | Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme | |
| IE780431L (en) | Imidazole 4, 5-dicarboxamides; herbicides | |
| NO175776C (no) | 1-aminopropandiol-2,3 med höy renhet, samt fremgangsmåte for fremstilling av forbindelsen | |
| PE23298A1 (es) | Forma cristalina alternativa de tazofelona | |
| EA199800364A1 (ru) | Новая кристаллическая форма морфин-6-глюкуронида | |
| JPS5398775A (en) | Gas phase growth unit | |
| NL7900117A (nl) | Werkwijze voor de bereiding van kristallijne maltose met een extreem hoge zuiverheid. | |
| IT7927285A0 (it) | Processo per la sintesi di steroidi. | |
| CA2147264A1 (en) | Vitamin d derivatives and a process for producing them | |
| RU95112573A (ru) | Способ получения 9-аминокамптотецина, промежуточные продукты, способ их получения и фармкомпозиция | |
| JPS5373507A (en) | Crystallization of pentaerythritol | |
| ES8105367A1 (es) | Perfeccionamientos en o relacionados con compuestos organi- cos | |
| AU6008080A (en) | Crucible assembly for growing monocrystalline bodies from the melt | |
| ES8101609A1 (es) | Un derivado de 7x-metoxicefalosporina | |
| JPS52125108A (en) | Synthesis of 1,1,1-trimethoxyethane | |
| MX156076A (es) | Procedimiento para preparar esteres fluorofenoxibencilicos | |
| JPS51122043A (en) | Process for preparation of 3-hydroxy-5- cycloxycyclopento-1-ene deriva tives | |
| CA2032311A1 (en) | 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors | |
| JPS532476A (en) | Synthesis of 4-substituted-dithio-2-azetidinone derivatives | |
| JPS5427582A (en) | Preparation of dinucleoside triphosphate | |
| JPS55162730A (en) | Preparation of hydoxycitronellal | |
| AR247877A1 (es) | Procedimiento para preparar desoxiespergualina triclorhidrato cristalizado bajo la forma beta. | |
| JPS5265261A (en) | Synthesis of 1alpha-hyaroxy-provitamine d compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |